Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
EV/Core EBITDA

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results

GENPHARMASEC Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023
   EV/Core EBITDA(x) 153.67244.10

What is the latest EV/Core EBITDA ratio of GENPHARMASEC ?

The latest EV/Core EBITDA ratio of GENPHARMASEC is 153.67 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar2024153.67
Mar2023244.10

How is EV/Core EBITDA of GENPHARMASEC Trending?

Years EV/Core EBITDA % Change
Mar2024 153.67
-37.05
Mar2023 244.1 -

Other Financial Ratios of GENPHARMASEC


Compare EV/Core EBITDA ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹110.2 Cr -2.5% -2% -16.3% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹10,749.2 Cr 9.2% 8.6% 38.6% Stock Analytics
KIRI INDUSTRIES ₹3,045.4 Cr -4.4% -6% 63.4% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹2,074.2 Cr 1.2% 1.3% -8.2% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,224.6 Cr 2.5% 14.1% 51.2% Stock Analytics
BODAL CHEMICALS ₹933.3 Cr -3.4% -2.4% -2.7% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

-2.5%

-2%

-16.3%

SENSEX

-1.6%

-3.4%

0.9%


You may also like the below Video Courses